Citation Impact

50 standout
Sub-graph 1 of 25

Citing Papers

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
2024 Standout
Multi-stage mechanisms of tumor metastasis and therapeutic strategies
2024 Standout
2 intermediate papers

Works of Jun Yamamura being referenced

The Difference in Prognostic Outcomes Between De Novo Stage IV and Recurrent Metastatic Patients with Hormone Receptor-positive, HER2-negative Breast Cancer
2018
Phase I study of combination therapy with weekly paclitaxel and cyclophosphamide for advanced or recurrent breast cancer
2009

Author Peers

Author Oncology PRM Cancer Research Last Decade Papers Cites
Jun Yamamura 148 67 118 38 315
Andreas Jørgensen 22 1.1k
Nemal S. Gobalasingham 1 2 16 481
Y. Abe 5 1 2 20 471
S. T. Mayne 472 751 293 30 2.8k
J.J.F.E. de Wilde 24 332

All Works

Loading papers...

Rankless by CCL
2026